TY - JOUR
T1 - Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain
AU - Ivorra, José Luis
AU - Rivero, Olga
AU - Costas, Javier
AU - Iniesta, Raquel
AU - Arrojo, Manuel
AU - Ramos-Ríos, Ramón
AU - Carracedo, Ángel
AU - Palomo, Tomas
AU - Rodriguez-Jimenez, Roberto
AU - Cervilla, Jorge
AU - Gutiérrez, Blanca
AU - Molina, Esther
AU - Arango, Celso
AU - Álvarez, Mar
AU - Pascual, Juan C.
AU - Pérez, Víctor
AU - Saiz, Pilar Alejandra
AU - García-Portilla, María Paz
AU - Bobes, Julio
AU - González-Pinto, Ana
AU - Zorrilla, Iñaki
AU - Haro, Josep María
AU - Bernardo, Miguel
AU - Baca-García, Enrique
AU - González, José Carlos
AU - Hoenicka, Janet
AU - Moltó, María Dolores
AU - Sanjuán, Julio
N1 - Copyright © 2014. Published by Elsevier B.V.
PY - 2014/10
Y1 - 2014/10
N2 - Genome wide association studies (GWAS) has allowed the discovery of some interesting risk variants for schizophrenia (SCZ). However, this high-throughput approach presents some limitations, being the most important the necessity of highly restrictive statistical corrections as well as the loss of statistical power inherent to the use of a Single Nucleotide Polymorphism (SNP) analysis approach. These problems can be partially solved through the use of a polygenic approach. We performed a genotyping study in SCZ using 86 previously associated SNPs identified by GWAS of SCZ, bipolar disorder (BPD) and autistic spectrum disorder (ASD) patients. The sample consisted of 3063 independent cases with DSM-IV-TR diagnosis of SCZ and 2847 independent controls of European origin from Spain. A polygenic score analysis was also used to test the overall effect on the SCZ status. One SNP, rs12290811, located in the ODZ4 gene reached statistical significance (p=1.7×10(-4), Allelic odds ratio=1.21), a value very near to those reported in previous GWAS of BPD patients. In addition, 4 SNPs were close to the significant threshold: rs3850333, in the NRXN1 gene; rs6932590, at MHC; rs2314398, located in an intergenic region on chromosome 2; and rs1006737, in the CACNA1C gene. We also found that 74% of the studied SNPs showed the same tendency (risk or protection alleles) previously reported in the original GWAS (p<0.001). Our data strengthen the polygenic component of susceptibility to SCZ. Our findings show ODZ4 as a risk gene for SCZ, emphasizing the existence of common vulnerability in psychosis.
AB - Genome wide association studies (GWAS) has allowed the discovery of some interesting risk variants for schizophrenia (SCZ). However, this high-throughput approach presents some limitations, being the most important the necessity of highly restrictive statistical corrections as well as the loss of statistical power inherent to the use of a Single Nucleotide Polymorphism (SNP) analysis approach. These problems can be partially solved through the use of a polygenic approach. We performed a genotyping study in SCZ using 86 previously associated SNPs identified by GWAS of SCZ, bipolar disorder (BPD) and autistic spectrum disorder (ASD) patients. The sample consisted of 3063 independent cases with DSM-IV-TR diagnosis of SCZ and 2847 independent controls of European origin from Spain. A polygenic score analysis was also used to test the overall effect on the SCZ status. One SNP, rs12290811, located in the ODZ4 gene reached statistical significance (p=1.7×10(-4), Allelic odds ratio=1.21), a value very near to those reported in previous GWAS of BPD patients. In addition, 4 SNPs were close to the significant threshold: rs3850333, in the NRXN1 gene; rs6932590, at MHC; rs2314398, located in an intergenic region on chromosome 2; and rs1006737, in the CACNA1C gene. We also found that 74% of the studied SNPs showed the same tendency (risk or protection alleles) previously reported in the original GWAS (p<0.001). Our data strengthen the polygenic component of susceptibility to SCZ. Our findings show ODZ4 as a risk gene for SCZ, emphasizing the existence of common vulnerability in psychosis.
KW - Adolescent
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Area Under Curve
KW - Case-Control Studies
KW - European Continental Ancestry Group
KW - Female
KW - Genetic Predisposition to Disease
KW - Genome-Wide Association Study
KW - Humans
KW - Male
KW - Membrane Glycoproteins
KW - Middle Aged
KW - Models, Genetic
KW - Multifactorial Inheritance
KW - Polymorphism, Single Nucleotide
KW - ROC Curve
KW - Schizophrenia
KW - Spain
KW - Young Adult
U2 - 10.1016/j.schres.2014.07.004
DO - 10.1016/j.schres.2014.07.004
M3 - Article
C2 - 25124521
SN - 0920-9964
VL - 159
SP - 107
EP - 113
JO - Schizophrenia Research
JF - Schizophrenia Research
IS - 1
ER -